-
1دورية أكاديمية
المؤلفون: Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, Philipp Reichert, Calin-Petru Manta, Mohamed H.S. Awwad, Sandra Sauer, Uta Bertsch, Britta Besemer, Roland Fenk, Mathias Hänel, Markus Munder, Katja C. Weisel, Igor W. Blau, Andreas Neubauer, Carsten Müller-Tidow, Marc S. Raab, Hartmut Goldschmidt, Stefanie Huhn, for the German-speaking Myeloma Multicenter Group (GMMG)
المصدر: Cancers, Vol 12, Iss 8, p 2322 (2020)
مصطلحات موضوعية: multiple myeloma (MM), minimal residual disease (MRD), next-generation sequencing (NGS), multicolor flow cytometry (MFC), EuroFlow, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Marc-Andrea Baertsch, Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Markus Munder, Stephan Fuhrmann, Ulrich Dührsen, Peter Brossart, Kai Neben, Jana Schlenzka, Christina Kunz, Marc S. Raab, Jens Hillengaß, Anna Jauch, Anja Seckinger, Dirk Hose, Steffen Luntz, Pieter Sonneveld, Henk Lokhorst, Hans Martin, Martin Goerner, Martin Hoffmann, Hans-Walter Lindemann, Helga Bernhard, Igor W. Blau, Christof Scheid, Britta Besemer, Katja C. Weisel, Mathias Hänel, Jan Dürig, Hartmut Goldschmidt, German-Speaking Myeloma Multicenter Group (GMMG)
المصدر: Blood Cancer Journal, Vol 11, Iss 1, Pp 1-10 (2021)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2044-5385
-
3دورية أكاديمية
المؤلفون: Mai, Elias K.Aff1, Hielscher, Thomas, Bertsch, Uta, Schlenzka, Jana, Salwender, Hans J., Munder, Markus, Gerecke, Christian, Dührsen, Ulrich, Brossart, Peter, Neben, Kai, Hillengass, Jens, Raab, Marc S., Merz, Maximilian, Baertsch, Marc-Andrea, Jauch, Anna, Hose, Dirk, Martin, Hans, Lindemann, Hans-Walter, Blau, Igor W., Scheid, Christof, Weisel, Katja C., Goldschmidt, HartmutAff1, Aff15, for the German-speaking Myeloma Multicenter Group (GMMG)
المصدر: Leukemia. 33(1):258-261
-
4دورية أكاديمية
المؤلفون: Eva-Maria Klein, Diana Tichy, Hans J. Salwender, Elias K. Mai, Jan Duerig, Katja C. Weisel, Axel Benner, Uta Bertsch, Mabast Akhavanpoor, Britta Besemer, Markus Munder, Hans-Walter Lindemann, Dirk Hose, Anja Seckinger, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Stephan Fuhrmann, Peter Brossart, Martin Goerner, Helga Bernhard, Marc S. Raab, Igor W. Blau, Mathias Haenel, Christof Scheid, Hartmut Goldschmidt, on behalf of the German-Speaking Myeloma Multicenter Group (GMMG)
المصدر: Cancers, Vol 13, Iss 19, p 4856 (2021)
مصطلحات موضوعية: multiple myeloma, prognostic factors, serum free light chain ratio normalization, immune reconstitution, time-dependent analysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5
المؤلفون: Lisa B. Leypoldt, Anne Marie Asemissen, Britta Besemer, Mathias Haenel, Igor Wolfgang Blau, Martin Görner, Yon-Dschun Ko, Hans Christian Reinhardt, Peter Staib, Christoph Mann, Raphael Lutz, Markus Munder, Ullrich Graeven, Rudolf Peceny, Hans Salwender, Anna Jauch, Manola Zago, Axel Benner, Diana Tichy, Carsten Bokemeyer, Hartmut Goldschmidt, Katja C. Weisel, German Speaking Myeloma Multicenter Group (GMMG)
المصدر: SSRN Electronic Journal.
مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, Study drug, Population, Ethics committee, Front line, Interim analysis, Safety profile, Informed consent, Family medicine, Induction therapy, medicine, Business, education
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3b70798192651ed5a20c75c16776d716
https://doi.org/10.2139/ssrn.3790459 -
6دورية أكاديمية
المؤلفون: Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Hundemer M; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Hofmeister-Mielke N; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Reichert P; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Manta CP; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Awwad MHS; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Sauer S; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Bertsch U; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, 69120 Heidelberg, Germany., Besemer B; Department of Hematology, Oncology and Immunology, University Hospital Tübingen, 72076 Tübingen, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, 40225 Düsseldorf, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, 09113 Chemnitz, Germany., Munder M; Department of Internal Medicine III, University Medical Center Mainz, 55131 Mainz, Germany., Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Department of Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, 10117 Berlin, Germany., Neubauer A; Department of Hematology, Oncology and Immunology, Philipps-University Marburg, 35043 Marburg, Germany., Müller-Tidow C; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Raab MS; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany., Goldschmidt H; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, 69120 Heidelberg, Germany., Huhn S; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, 69120 Heidelberg, Germany., For The German-Speaking Myeloma Multicenter Group Gmmg
المصدر: Cancers [Cancers (Basel)] 2020 Aug 18; Vol. 12 (8). Date of Electronic Publication: 2020 Aug 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE